VCM
IRMD icon

Voleon Capital Management’s iRadimed IRMD Stock Holding History

Voleon Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
12,772
-11,440
-47% -$1.04M 0.02% 442
2026
Q1 		$2.33M Buy
24,212
+17,639
+268% +$1.76M 0.05% 307
2025
Q4 		$639K Buy
6,573
+1,515
+30% +$130K 0.01% 529
2025
Q3 		$360K Sell
5,058
-110
-2% -$7.33K 0.01% 673
2025
Q2 		$309K Sell
5,168
-3,927
-43% -$215K 0.02% 399
2025
Q1 		$477K Sell
9,095
-5,521
-38% -$310K 0.04% 261
2024
Q4 		$804K Buy
+14,616
New +$769K 0.06% 223

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voleon Capital Management's IRMD Position: Q2 2026 in Review

Voleon Capital Management reduced its iRadimed (IRMD) stake by 47% in Q2 2026, selling an estimated $1.04M and leaving 12,772 shares worth $1.22M. The position accounts for 0.02% of the portfolio, ranked #442.

Voleon Capital Management first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.33M in Q1 2026. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Voleon Capital Management held 12,772 shares of iRadimed worth $1.22M as of Q2 2026.
  • Voleon Capital Management sold 11,440 iRadimed shares in Q2 2026, an estimated $1.04M.
  • iRadimed made up 0.02% of Voleon Capital Management's portfolio in Q2 2026, its #442 holding.
  • Voleon Capital Management first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
  • Voleon Capital Management's iRadimed position peaked at $2.33M in Q1 2026.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.